Triptorelin acetate cas : 57773-63-4

Unit Size	100 mcg/vial, 2 mg, 5mg, 10 mg
Unit Quantity	1 Vial
CAS NO.	57773-63-4
Synonyms	Triptorelin Acetate, GnRH
Molecular Formula	C₆₄H₈₂N₁₈O₁₃
Molecular Weight	1311.45
Sequence	pGlu-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH2
Appearance	White Powder
Purity	98.86%
Identity (ESI-MS)	1311.45±1.0
Source	Chemical Synthesis
Storage	Lyophilized powder is stable at room temperature for 90 days,however it should be stored in a freezer below -8C for any extended period of time. After reconstituting it should be refrigerated at temperatures not to exceed 36 F.
Reports	MS Report 1 MS Report 2
Terms	The products we offer are intended for laboratory research use only. Please familiarize yourself with our Terms of Service prior to ordering.

Triptorelin (GnRH)

Triptorelin, a decapeptide (pGlu-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH2), is a gonadotropin-releasing hormone agonist (GnRH agonist) used as the acetate or pamoate salts. Triptorelin raises testosterone levels by causing constant stimulation of the pituitary, it decreases pituitary secretion of gonadotropins luteinizing hormone (LH) and follicle stimulating hormone (FSH). Like other GnRH agonists, triptorelin may be used in the treatment of hormone-responsive cancers such as prostate cancer or breast cancer, precocious puberty, estrogen-dependent conditions (such as endometriosis or uterine fibroids), and in assisted reproduction. Triptorelin is marketed under the brand names Decapeptyl (Ipsen) and Diphereline and Gonapeptyl (Ferring Pharmaceuticals). In the United States, it is sold by Watson as Trelstar.In Middle East Triptorelin is marketed under the brand name Variopeptyl (Varian Darou Pajooh). In India, Dr. Reddy’s Laboratories has launched recently Triptorelin under the brand name “Pamorelin LA”. During the treatment of prostate cancer it does cause a surge of testosterone (an initial uplevel of testosterone levels), known as a flare effect. In men a reduction of serum testosterone levels into the range normally seen after surgical castration occurs approximately two to four weeks after initiation of therapy. Systematic IUPAC Name: [d-Trp6]GnRH [edit]References Lahlou N, Carel JC, Chaussain JL, Roger M (July 2000). “Pharmacokinetics and pharmacodynamics of GnRH agonists: clinical implications in pediatrics”. J Pediatr Endocrinol Metab .

Important Notification: All of our products and services listed in this website are for research or production use only, not for direct human use.